Table I.
Patient and tumor characteristics.
| N 132 |
Percent 100% |
||
|---|---|---|---|
| Age (years) | Median | 62 | |
| Range | 36–80 | ||
| Sex | Male | 104 | 79% |
| Female | 28 | 21% | |
| cT | T1/T2 | 18 | 14% |
| T3/T4 | 111 | 85% | |
| TX | 2 | 2% | |
| cN | Positive | 92 | 70% |
| Negative | 40 | 30% | |
| cM | M0/M1a | 121 | 92% |
| M1 | 11 | 8% | |
| pT | T0/Tis | 46 | 35% |
| T1/T2 | 49 | 37% | |
| T3/T4 | 37 | 28% | |
| pN | Positive | 45 | 34% |
| Negative | 87 | 66% | |
| Histology | SCC | 110 | 83% |
| Adenocarcinoma | 22 | 17% | |
| Margins | Negative | 109 | 83% |
| Close/Positive | 23 | 17% | |
| LVI | Yes | 9 | 7% |
| No | 121 | 92% | |
| N/A | 2 | 2% | |
| Ulceration | Yes | 7 | 5% |
| No | 109 | 83% | |
| N/A | 16 | 12% | |
| Radiation technique | IMRT | 37 | 28% |
| 3D-CRT | 93 | 70% | |
| Peri-neural invasion | Yes | 8 | 6% |
| No | 121 | 92% | |
| N/A | 3 | 2% | |